Recently [7], [19], two different prospective multicenter studies suggested that phi and %p2PSA provided significantly better clinical performance than other PSA molecular forms assays in detecting PCa in 2–10 ng/ml tPSA range. Here, KLK3 is linked to posterior cortical atrophy.